FDA Drug Safety Communication: New boxed warning for severe liver injury with arthritis drug Arava (leflunomide)
This is a discussion on FDA Drug Safety Communication: New boxed warning for severe liver injury with arthritis drug Arava (leflunomide) within the FDA News forum, part of the Industry News and Updates category; [07-13-2010] The U.S. Food and Drug Administration (FDA) is adding information on severe liver injury to the ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
07-13-2010, 02:30 PM
|
|||
|
|||
FDA Drug Safety Communication: New boxed warning for severe liver injury with arthritis drug Arava (leflunomide)
[07-13-2010] The U.S. Food and Drug Administration (FDA) is adding information on severe liver injury to the Boxed Warning of Arava (leflunomide), a drug used to treat rheumatoid arthritis - to highlight the risk of severe liver injury in patients using this drug and how this risk may be reduced.
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| FDA Drug Safety Communication: Completed safety review of Xenical/Alli (orlistat) and severe liver injury | industry_news | FDA News | 0 | 05-26-2010 11:40 AM |
| FDA Drug Safety Communication: New Boxed Warning on severe liver injury with propylthiouracil | industry_news | FDA News | 0 | 04-21-2010 01:06 PM |
| FDA Drug Safety Communication: Serious liver disorder associated with the use of Videx/Videx EC (didanosine) | industry_news | FDA News | 0 | 02-06-2010 06:38 AM |
| FDA Drug Safety Communication: Serious liver disorder associated with the use of Videx/Videx EC (didanosine) | industry_news | FDA News | 0 | 01-29-2010 01:36 PM |
© 2008 DrugManagementForum™ powered by |
 |